标题
Neuroprotective effects of fingolimod in mouse models of Parkinson’s disease
作者
关键词
-
出版物
FASEB JOURNAL
Volume 31, Issue 1, Pages 172-179
出版商
FASEB
发表日期
2016-09-27
DOI
10.1096/fj.201600751r
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation
- (2016) Qiang Liu et al. NATURE NEUROSCIENCE
- Non-invasive tracking of CD4+ T cells with a paramagnetic and fluorescent nanoparticle in brain ischemia
- (2015) Wei-Na Jin et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- FTY720 attenuates excitotoxicity and neuroinflammation
- (2015) Raffaela Cipriani et al. Journal of Neuroinflammation
- A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity
- (2015) Qiang Liu et al. NEUROPHARMACOLOGY
- Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson’s disease and in MPP+-treated MN9D cells in vitro
- (2015) M. Sivasubramanian et al. NEUROSCIENCE
- Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide
- (2014) Emanuela Colombo et al. ANNALS OF NEUROLOGY
- Sphingosine Kinase 1 and Sphingosine-1-Phosphate in Oxidative Stress Evoked by 1-Methyl-4-Phenylpyridinium (MPP+) in Human Dopaminergic Neuronal Cells
- (2014) Joanna Pyszko et al. MOLECULAR NEUROBIOLOGY
- Disturbed mitochondrial dynamics and neurodegenerative disorders
- (2014) Florence Burté et al. Nature Reviews Neurology
- The ongoing pursuit of neuroprotective therapies in Parkinson disease
- (2014) Dilan Athauda et al. Nature Reviews Neurology
- Ischemic neurons recruit natural killer cells that accelerate brain infarction
- (2014) Y. Gan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic prospects for Parkinson disease
- (2013) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- A Novel Nicotinic Mechanism Underlies -Amyloid-Induced Neuronal Hyperexcitation
- (2013) Q. Liu et al. JOURNAL OF NEUROSCIENCE
- Genetic deficiency of β2-containing nicotinic receptors attenuates brain injury in ischemic stroke
- (2013) Q. Liu et al. NEUROSCIENCE
- A Guide to Neurotoxic Animal Models of Parkinson's Disease
- (2013) K. Tieu Cold Spring Harbor Perspectives in Medicine
- Animal models of Parkinson’s disease
- (2012) Fabio Blandini et al. FEBS Journal
- Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway
- (2012) Li Gong et al. JOURNAL OF NEUROCHEMISTRY
- Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome
- (2012) R. Deogracias et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
- (2011) Susan Duty et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neurotoxin-based models of Parkinson's disease
- (2011) J. Bové et al. NEUROSCIENCE
- Levodopa: the story so far
- (2010) Alison Abbott NATURE
- Molecular and clinical prodrome of Parkinson disease: implications for treatment
- (2010) Anthony H. V. Schapira et al. Nature Reviews Neurology
- FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
- (2010) J. W. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel Nicotinic Acetylcholine Receptor Subtype in Basal Forebrain Cholinergic Neurons with High Sensitivity to Amyloid Peptides
- (2009) Q. Liu et al. JOURNAL OF NEUROSCIENCE
- Activation of Sphingosine 1-Phosphate Receptor-1 by FTY720 Is Neuroprotective After Ischemic Stroke in Rats
- (2009) Yu Hasegawa et al. STROKE
- Principles of bioactive lipid signalling: lessons from sphingolipids
- (2008) Yusuf A. Hannun et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
- (2007) Kumlesh K. Dev et al. PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started